The Unresolved Role of Interferon-λ in Asthma Bronchiale

Department of Molecular Pneumology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Universitätsklinikum Erlangen, Erlangen, Germany

Asthma bronchiale is a disease of the airways with increasing incidence, that often begins during infancy. So far, therapeutic options are mainly symptomatic and thus there is an increasing need for better treatment and/or prevention strategies. Human rhinoviruses (HRVs) are a major cause of asthma exacerbations and might cause acute wheezing associated with local production of pro-inflammatory mediators resulting in neutrophilic inflammatory response. Viral infections induce a characteristic activation of immune response, e.g., TLR3, 4, 7, 8, 9 in the endosome and their downstream targets, especially MyD88. Moreover, other cytoplasmic pattern recognition molecules (PRMs) like RIG1 and MDA5 play important roles in the activation of interferons (IFNs) of all types. Depending on the stimulation of the different PRMs, the levels of the IFNs induced might differ. Recent studies focused on Type I IFNs in samples from control and asthma patients. However, the administration of type I IFN-α was accompanied by side-effects, thus this possible therapy was abandoned. Type III IFN-λ acts more specifically, as fewer cells express the IFN-λ receptor chain 1. In addition, it has been shown that asthmatic mice treated with recombinant or adenoviral expressed IFN-λ2 (IL–28A) showed an amelioration of symptoms, indicating that treatment with IFN-λ might be beneficial for asthmatic patients.

 
Download Article (PDF)         Full text (html) 
 

 

(You must be logged in to add and reply comments)

Interasma on Twitter

Interasma Top story: Allergy, Asthma and Immunology: Earlier smoking after waking and the… https://t.co/4D1fp6c8wl, see more https://t.co/CpGiFuOOYd
12hreplyretweetfavorite
Interasma RT @worldallergy: Top story: Juan C Ivancevich MD on Twitter: "“Mount Sinai researchers have iden… https://t.co/F6trY5HZUu, see more https:…
16hreplyretweetfavorite
Interasma RT @Aller_MD: “Weekly Clinical Case Challenge from Derm101” https://t.co/pF9S73bifi https://t.co/RIhysTcqLT
16hreplyretweetfavorite
Interasma RT @Aller_MD: Earlier smoking after waking and the risk of asthma: a cross-sectional study using NHANES data https://t.co/TcZ0vH1zf9
16hreplyretweetfavorite
Interasma RT @Aller_MD: The latest Allergy, Asthma & Immunology! https://t.co/iA6gjSf7NY Thanks to @DrAnneEllis @susanprescott88 #tb #vaccine
16hreplyretweetfavorite

Editor: Juan C. Ivancevich, MD

Copyright © Interasma 2003-2017  •  Terms of Use  •  Privacy Policy  •  Contact Us  •  Sitemap

Powered by FREI SA

InterAsma